Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma

Journal of Proteome Research

Volumn 7, Issue 2, 2008, Pages 603-610

  Ressom, Habtom W ^a   Varghese, Rency S ^a   Goldman, Lenka ^a   An, Yanming ^a   Loffredo, Christopher A ^a   Abdel Hamid, Mohamed ^b   Kyselova, Zuzana ^c   Mechref, Yehia ^c   Novotny, Milos ^c   Drake, Steven K ^d   Goldman, Radoslav ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b MINIA UNIVERSITY   (Egypt)

^c National Center for Glycomics and Glycoproteomics Bloomington   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Glycomics; Liver cancer; Peak selection; Proteomics

Indexed keywords

BIOLOGICAL MARKER; GLYCAN; PEPTIDE;

AGE DISTRIBUTION; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FEMALE; GENETIC ALGORITHM; GLYCOBIOLOGY; HIGH RISK POPULATION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ALGORITHMS; AMINO ACID SEQUENCE; CARCINOMA, HEPATOCELLULAR; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; PEPTIDES; POLYSACCHARIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 39749084727     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr0705237     Document Type: Article

References (25)

1. Marrero, J. A. Screening tests for hepatocellular carcinoma. Clin Liver Dis 2005, 9 (2), 235-251.
2. Gupta, S.; Bent, S.; Kohlwes, J. Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann. Intern. Med. 2003, 139 (1), 46-50.
3. Orvisky, E.; Drake, S. K.; Martin, B. M.; Abdel-Hamid, M.; Ressom, H. W.; Varghese, R. S.; An, Y.; Saha, D.; Hortin, G. L.; Loffredo, C. A.; Goldman, R. Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma. Proteomics 2006, 6 (9), 2895-2902.
4. Ressom, H. W.; Varghese, R. S.; Abdel-Hamid, M.; Abdel-Latif Eissa, S.; Saha, D.; Goldman, L.; Petricoin, E. F.; Conrads, T. P.; Veenstra, T. D.; Loffredo, C. A.; Goldman, R. Analysis of mass spectral serum profiles for biomarker selection. Bioinformatics 2005, 21 (21), 4039-4045.
5. Ressom, H. W.; Varghese, R. S.; Drake, S. K.; Hortin, G. L.; Abdel-Hamid, M.; Loffredo, C. A.; Goldman, R. Peak selection from MALDI-TOF mass spectra using ant colony optimization. Bioinformatics 2007, 23 (5), 619-626.
6. Schwegler, E. E.; Cazares, L.; Steel, L. F.; Adam, B. L.; Johnson, D. A.; Semmes, O. J.; Block, T. M.; Marrero, J. A.; Drake, R. R. SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology 2005, 41 (3), 634-642.
7. Lee, I. N.; Chen, C. H.; Sheu, J. C.; Lee, H. S.; Huang, G. T.; Chen, D. S.; Yu, C. Y.; Wen, C. L.; Lu, F. J.; Chow, L. P. Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach. Proteomics 2006, 6 (9), 2865-2873.
8. Ward, D. G.; Cheng, Y.; N'Kontchou, G.; Thar, T. T.; Barget, N.; Wei, W.; Billingham, L. J.; Martin, A.; Beaugrand, M.; Johnson, P. J. Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis. Br. J. Cancer 2006, 94 (2), 287-292.
9. Luk, J. M.; Lam, C. T.; Siu, A. F.; Lam, B. Y.; Ng, I. O.; Hu, M. Y.; Che, C. M.; Fan, S. T. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics 2006, 6 (3), 1049-1057.
10. Callewaert, N.; Van Vlierberghe, H.; Van Hecke, A.; Laroy, W.; Delanghe, J.; Contreras, R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat. Med. 2004, 10 (4), 429-434.
11. Ludwig, J. A.; Weinstein, J. N. Biomarkers in cancer staging, prognosis and treatment selection. Nat. Rev. Cancer 2005, 5 (11), 845-856.
12. Taketa, K.; Endo, Y.; Sekiya, C.; Tanikawa, K.; Koji, T.; Taga, H.; Satomura, S.; Matsuura, S.; Kawai, T.; Hirai, H. A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res. 1993, 53 (22), 5419-5423.
13. Shiraki, K.; Takase, K.; Tameda, Y.; Hamada, M.; Kosaka, Y.; Nakano, T. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Hepatology 1995, 22 (3), 802-807.
14. Marrero, J. A.; Romano, P. R.; Nikolaeva, O.; Steel, L.; Mehta, A.; Fimmel, C. J.; Comunale, M. A.; D'Amelio, A.; Lok, A. S.; Block, T. M. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J. Hepatol. 2005, 43 (6), 1007-1012.
15. Comunale, M. A.; Lowman, M.; Long, R. E.; Krakover, J.; Philip, R.; Seeholzer, S.; Evans, A. A.; Hann, H. W.; Block, T. M.; Mehta, A. S. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J. Proteome Res. 2006, 5 (2), 308-315.
16. Turner, G. A. N-glycosylation of serum proteins in disease and its investigation using lectins. Clin. Chim. Acta 1992, 208 (3), 149-171.
17. Lee, S. J.; Evers, S.; Roeder, D.; Parlow, A. F.; Risteli, J.; Risteli, L.; Lee, Y. C.; Feizi, T.; Langen, H.; Nussenzweig, M. C. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science 2002, 295 (5561), 1898-901.
18. Kyselova, Z.; Mechref, Y.; Al Bataineh, M. M.; Dobrolecki, L. E.; Hickey, R. J.; Vinson, J.; Sweeney, C. J.; Novotny, M. V. Alterations in the serum glycome due to metastatic prostate cancer. J. Proteome Res. 2007, 6 (5), 1822-1832.
19. Zhao, J.; Qiu, W.; Simeone, D. M.; Lubman, D. M. N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis. J. Proteome Res. 2007, 6 (3), 1126-1138.
20. Kang, P.; Mechref, Y.; Klouckova, I.; Novotny, M. V. Solid-phase permethylation of glycans for mass spectrometric analysis. Rapid Commun. Mass Spectrom. 2005, 19 (23), 3421-3428.
21. Nada, O.; Abdel-Hamid, M.; Ismail, A.; El Shabrawy, L.; Sidhom, K. F.; El Badawy, N. M.; Ghazal, F. A.; El Daly, M.; El Kafrawy, S.; Esmat, G.; Loffredo, C. A. The role of the tumor necrosis factor (TNF) - Fas L and HCV in the development of hepatocellular carcinoma. J. Clin. Virol. 2005, 34 (2), 140-146.
22. Ezzat, S.; Abdel-Hamid, M.; Eissa, S. A.; Mokhtar, N.; Labib, N. A.; El-Ghorory, L.; Mikhail, N. N.; Abdel-Hamid, A.; Hifnawy, T.; Strickland, G. T.; Loffredo, C. A. Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. Int. J. Hyg. Environ. Health 2005, 208 (5), 329-339.
23. AJCC Cancer Staging Manual, 6th ed.; American College of Surgeons; Lippincott-Raven: Philadelphia, 2002.
24. Abdel-Hamid, M.; Edelman, D. C.; Highsmith, W. E.; Constantine, N. T. Optimization, assessment, and proposed use of a direct nested reverse transcription-polymerase chain reaction protocol for the detection of hepatitis C virus. J. Hum. Virol. 1997, 1 (1), 58-65.
25. Mechref, Y.; Novotny, M. V. Mass spectrometric mapping and sequencing of N-linked oligosaccharides derived from submicrogram amounts of glycoproteins. Anal. Chem. 1998, 70 (3), 455-463.